Axoltis Pharma will attend Neuroscience Virtual Partnering on November 9-12. Yann Godfrin, Chief Executive Officer and Luca Bolliger, Chief Business Officer, will be delighted to meet you there and discuss potential partnerships for the development of our innovative drug-candidate for neurological disorders !